Home/Filings/4/0000950170-24-077518
4//SEC Filing

Arif Bilal 4

Accession 0000950170-24-077518

CIK 0000873303other

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 8:00 PM ET

Size

22.0 KB

Accession

0000950170-24-077518

Insider Transaction Report

Form 4
Period: 2024-06-21
Arif Bilal
Chief Tech Ops Officer
Transactions
  • Sale

    Common Stock

    2024-06-25$163.23/sh3,898$636,27117,363 total
  • Award

    Performance Stock Units

    2024-06-21+6,2506,250 total
    Common Stock (6,250 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2024-06-216,2500 total
    Common Stock (6,250 underlying)
  • Exercise/Conversion

    Common Stock

    2024-06-21+6,25031,472 total
  • Sale

    Common Stock

    2024-06-24$163.83/sh1,055$172,84122,485 total
  • Sale

    Common Stock

    2024-06-24$164.61/sh300$49,38322,185 total
  • Sale

    Common Stock

    2024-06-24$167.13/sh224$37,43721,261 total
  • Tax Payment

    Common Stock

    2024-06-24$164.64/sh2,352$387,23329,120 total
  • Sale

    Common Stock

    2024-06-24$166.10/sh700$116,27021,485 total
  • Sale

    Common Stock

    2024-06-24$162.31/sh5,580$905,69023,540 total
Footnotes (8)
  • [F1]Represents the number of shares earned and vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU.
  • [F2]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 1, 2024.
  • [F3]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2024.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.25 to $163.21, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.35 to $164.18, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.38 to $164.91, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.69 to $166.44, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.91 to $167.36, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Documents

1 file

Issuer

Sarepta Therapeutics, Inc.

CIK 0000873303

Entity typeother

Related Parties

1
  • filerCIK 0001959750

Filing Metadata

Form type
4
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 8:00 PM ET
Size
22.0 KB